Panacea Biotec has secured a significant deal to supply bivalent oral polio vaccines valued at Rs 127.2 crore to the Central Medical Services Society. This crucial supply, confirmed via a Letter of Acceptance, will be delivered in multiple phases over 90 to 480 days, bolstering India's ongoing polio eradication efforts.
Panacea Biotec Ltd on Thursday said it will supply bivalent oral polio vaccines worth Rs 127.2 crore to the Central Medical Services Society, Ministry of Health and Family Welfare.
In a regulatory filing, Panacea Biotec said the Central Medical Services Society (CMSS) has accepted the company's offer for supply of bivalent oral polio vaccine against the tender issued by it through a Letter of Acceptance (LOA) dated October 8, 2025.
"As per the LOA, the company will supply the vaccine worth Rs 127.2 crore in several tranches over a period of 90 - 480 days from the date of issuance of LOA," it added.